| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5721214 | L'Encéphale | 2017 | 7 Pages |
Abstract
Additional studies are needed to confirm the efficacy of rTMS and tDCS in ADHD. rTMS could be used as an alternative therapy when methylphenidate is not well tolerated or shows an insufficient efficacy. Nevertheless, the optimal target, frequency and duration remain to be determined. tDCS can modulate attention in healthy subjects but data are insufficient in ADHD to conclude. It could be interesting to study its use in association with cognitive remediation to enhance its cognitive efficacy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
L. Brandejsky, J.-A. Micoulaud Franchi, R. Lopez, S. Bioulac, D. Da Fonseca, C. Daudet, L. Boyer, R. Richieri, C. Lançon,